IMARC Group has recently released a report titled "Gastritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033" that presents a comprehensive assessment of the gastritis market size. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the gastritis market.
Request a Sample Report: https://www.imarcgroup.com/gastritis-market/requestsample
Gastritis Market Size:
The gastritis market is anticipated to grow at a CAGR of 2.8% during 2023-2033
What is gastritis?
Gastritis is a medical condition classified by inflammation, irritation, or erosion of the stomach lining. It is primarily classified as either acute, which appears suddenly and is often severe, or chronic, which evolves gradually and could persist for several years. This disease can interfere with the normal functioning of the stomach, resulting in indigestion, bloating, and an early sense of fullness after a minor meal. Some of the other symptoms associated with this disease include abdominal discomfort or pain, nausea, vomiting, frequent belching or hiccupping, loss of appetite, heartburn, and evidence of blood in stool or vomit. It can be diagnosed by a comprehensive review of the patient's medical history and characteristic findings. The healthcare provider may conduct a physical examination to evaluate the abdomen for tenderness, bloating, or other signs of inflammation. Endoscopy is often recommended.
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/gastritis-market
What are the key drivers and trends in the gastritis market?
The gastritis market is primarily driven by the rising incidences of Helicobacter pylori infections, which can cause chronic inflammation and damage the stomach lining. Concurrent with this, the growing prevalence of risk factors such as stress, excessive alcohol consumption, prolonged use of nonsteroidal anti-inflammatory drugs, and bile reflux is strengthening the market growth. Additionally, the widespread adoption of proton pump inhibitors, such as omeprazole, esomeprazole, and pantoprazole, among others, aimed at reducing stomach acid production and aiding the healing of the inflamed stomach lining, is positively impacting the market growth. Moreover, the increasing application of probiotic supplements, which work by re-establishing gut flora balance and alleviating symptoms, is contributing to the market's growth. Furthermore, the emerging trend of minimally invasive argon plasma coagulation therapy, utilizing focused energy to coagulate and seal abnormal blood vessels, thereby mitigating the risk of complications, is aiding in market expansion.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the gastritis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the gastritis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Key Questions Answered in this Report:
- How has the gastritis market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the gastritis market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the gastritis market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Pruritus Market Report 2023-2033
Pericarditis Market Report 2023-2033
Psoriasis Market Report 2023-2033
Hypogonadism Market Report 2023-2033
How This Report Can Help You:
- The report on gastritis market presents a comprehensive overview and analysis of the epidemiology and market for this condition in the seven major markets (7MM): the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
- With insights into both current and emerging therapies in the 7MM, this report offers valuable information for businesses seeking to understand trends and opportunities within the gastritis market.
- The gastritis market report covers historical and forecasted market data, including epidemiology scenario, providing a reliable and informative resource for developing effective business strategies in 7MM.
- Our report on the gastritis market can help businesses stay abreast of the trends and drivers, gain a competitive edge and drive success.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
